Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lowrey

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The American Journal of Pathology|January 1, 1994
CD40 expression in Hodgkin's diseaseJ T O'Grady, S Stewart, J Lowrey, et al.
BMC Biochemistry|September 12, 2008
Mitochondrial oxidative phosphorylation in autosomal dominant optic atrophyVladimir I Mayorov, Angela J Lowrey, Valerie Biousse, et al.
Journal of Neuroendocrinology|September 30, 2000
Selective blockade of the mineralocorticoid receptor impairs hypothalamic-pituitary-adrenal axis expression of habituationM A Cole, B A Kalman, T W Pace, et al.
Plos One|July 13, 2018
Using citizen science to describe the prevalence and distribution of tick bite and exposure to tick-borne diseases in the United StatesNathan C Nieto, W Tanner Porter, Julie C Wachara, et al.
Journal of Environmental Radioactivity|August 9, 2021
Measurements of Argon-39 from locations near historic underground nuclear explosionsC Johnson, B Milbrath, J Lowrey, et al.
Plos One|May 25, 2019
Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latencyGretchen L Bentz, Angela J Lowrey, Dustin C Horne, et al.
Scientific Reports|July 4, 2019
The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-proteaseThomas L Selby, Natalie Biel, Matthew Varn, et al.
Antiviral Research|February 12, 2021
Effects of targeting sumoylation processes during latent and induced Epstein-Barr virus infections using the small molecule inhibitor ML-792Peter Garcia, Abigail Harrod, Shruti Jha, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 15, 2012
Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjectsAbhinay D Joshi, Michael J Pontecorvo, Chrisopher M Clark, et al.
Dementia and Geriatric Cognitive Disorders|August 9, 2017
Effectiveness of Florbetapir PET Imaging in Changing Patient ManagementMichael J Pontecorvo, Andrew Siderowf, Bruno Dubois, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The American Journal of Pathology|January 1, 1994
CD40 expression in Hodgkin's diseaseJ T O'Grady, S Stewart, J Lowrey, et al.
BMC Biochemistry|September 12, 2008
Mitochondrial oxidative phosphorylation in autosomal dominant optic atrophyVladimir I Mayorov, Angela J Lowrey, Valerie Biousse, et al.
Journal of Neuroendocrinology|September 30, 2000
Selective blockade of the mineralocorticoid receptor impairs hypothalamic-pituitary-adrenal axis expression of habituationM A Cole, B A Kalman, T W Pace, et al.
Plos One|July 13, 2018
Using citizen science to describe the prevalence and distribution of tick bite and exposure to tick-borne diseases in the United StatesNathan C Nieto, W Tanner Porter, Julie C Wachara, et al.
Journal of Environmental Radioactivity|August 9, 2021
Measurements of Argon-39 from locations near historic underground nuclear explosionsC Johnson, B Milbrath, J Lowrey, et al.
Plos One|May 25, 2019
Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latencyGretchen L Bentz, Angela J Lowrey, Dustin C Horne, et al.
Scientific Reports|July 4, 2019
The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-proteaseThomas L Selby, Natalie Biel, Matthew Varn, et al.
Antiviral Research|February 12, 2021
Effects of targeting sumoylation processes during latent and induced Epstein-Barr virus infections using the small molecule inhibitor ML-792Peter Garcia, Abigail Harrod, Shruti Jha, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 15, 2012
Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjectsAbhinay D Joshi, Michael J Pontecorvo, Chrisopher M Clark, et al.
Dementia and Geriatric Cognitive Disorders|August 9, 2017
Effectiveness of Florbetapir PET Imaging in Changing Patient ManagementMichael J Pontecorvo, Andrew Siderowf, Bruno Dubois, et al.
Pageof 2